Based on Kaplan-Meier analysis, we did not observe the significant associations of TET1 and TET2 expression with overall survival (OS) and disease-free survival (DFS) among both total AML and non-M3 AML (Figure 3). Here, TET2 is linked to acute myeloid leukemia.